Business & Entrepreneurship

WashU Olin Business School will host its annual spring symposium, aimed at improving health outcomes. The daylong event offers participants business-driven perspectives on health and the chance to connect with peers from WashU and beyond.

Four WashU researchers have been named senior members of the National Academy of Inventors: Rajan Chakrabarty, Vijay Ramani, Christina Stallings and Zhude Tu.

WashU has been named to the National Academy of Inventors’ Top 100 Worldwide Universities granted U.S. utility patents in 2025. The university is ranked 49 on the list, with 70 total patents.

High prescription drug prices are not caused by any single company or practice, but by the system itself, said WashU Law’s Rachel Sachs. If Congress wants lower drug prices, it has to fix the structure and incentives of the entire supply chain, said Sachs, an expert on prescription drug pricing.

Jeffrey Plunkett, a professor of practice in accounting at WashU Olin Business School, answers common questions about new tax rules, how changes in Internal Revenue System staffing could impact the filing process and who needs an accountant.

As WashU’s vice chancellor for innovation and commercialization, Doug Frantz helps speed scientific discoveries into real-world therapies and devices. He works to develop strategic partnerships with industry and enhance WashU’s commercialization efforts.

Xiumin Martin, a leading accounting scholar whose research deepens our understanding of finance markets and directly informs accounting policy and corporate governance, was installed in November as the inaugural Margaret Oung Distinguished Professor at Olin Business School.

The markets essentially shrugged when the U.S. removed Venezuelan President Nicolás Maduro in a special operation. But that could change if the U.S. follows through on other geopolitical threats, says political scientist Timm Betz at Washington University in St. Louis.

Everyone has reckoned with uncertainty. Should I switch majors? Can I be a better leader? Or, in the case of WashU alumnus Sam Goodwin, will I be slaughtered by my Syrian captors? Goodwin speaks about winning through uncertainty at Graham Chapel at 5:30 p.m. Wednesday, Jan. 21.

Startups built on WashU discoveries attracted a record $1.7 billion in private-sector investment over the past year, accelerating the commercialization of WashU innovations into life-changing diagnostics, therapeutics and medical devices.